Literature DB >> 1568757

Diabetes mellitus and hypertension.

M Epstein1, J R Sowers.   

Abstract

Diabetes mellitus and hypertension are common diseases that coexist at a greater frequency than chance alone would predict. Hypertension in the diabetic individual markedly increases the risk and accelerates the course of cardiac disease, peripheral vascular disease, stroke, retinopathy, and nephropathy. Our understanding of the factors that markedly increase the frequency of hypertension in the diabetic individual remains incomplete. Diabetic nephropathy is an important factor involved in the development of hypertension in diabetics, particularly type I patients. However, the etiology of hypertension in the majority of diabetic patients cannot be explained by underlying renal disease and remains "essential" in nature. The hallmark of hypertension in type I and type II diabetics appears to be increased peripheral vascular resistance. Increased exchangeable sodium may also play a role in the pathogenesis of blood pressure in diabetics. There is increasing evidence that insulin resistance/hyperinsulinemia may play a key role in the pathogenesis of hypertension in both subtle and overt abnormalities of carbohydrate metabolism. Population studies suggest that elevated insulin levels, which often occurs in type II diabetes mellitus, is an independent risk factor for cardiovascular disease. Other cardiovascular risk factors in diabetic individuals include abnormalities of lipid metabolism, platelet function, and clotting factors. The goal of antihypertensive therapy in the patient with coexistent diabetes is to reduce the inordinate cardiovascular risk as well as lowering blood pressure.

Entities:  

Mesh:

Year:  1992        PMID: 1568757     DOI: 10.1161/01.hyp.19.5.403

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  94 in total

Review 1.  Hypertension and diabetic retinopathy--what's the story?

Authors:  J T Gillow; J M Gibson; P M Dodson
Journal:  Br J Ophthalmol       Date:  1999-09       Impact factor: 4.638

2.  Diabetes mellitus and incidence of kidney cancer: a meta-analysis of cohort studies.

Authors:  S C Larsson; A Wolk
Journal:  Diabetologia       Date:  2011-01-28       Impact factor: 10.122

Review 3.  Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.

Authors:  T Baba; S Neugebauer; T Watanabe
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

4.  An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study.

Authors:  A Y T Wu; N C T Kong; F A de Leon; C Y Pan; T Y Tai; V T F Yeung; S J Yoo; A Rouillon; M R Weir
Journal:  Diabetologia       Date:  2004-12-23       Impact factor: 10.122

5.  The effect of global brain ischemia in normal and diabetic animals: the influence of calcium channel blockers.

Authors:  Joseph Levy; Zhengxian Zhu; Joseph C Dunbar
Journal:  Endocrine       Date:  2004-11       Impact factor: 3.633

Review 6.  Treatment of Hypertension in Patients with Diabetes Mellitus: a Contemporary Approach.

Authors:  Ben Alencherry; Luke J Laffin
Journal:  Curr Cardiol Rep       Date:  2021-01-23       Impact factor: 2.931

Review 7.  Drug treatment of hypertension complicating diabetes mellitus.

Authors:  M J MacLeod; J McLay
Journal:  Drugs       Date:  1998-08       Impact factor: 9.546

Review 8.  Nutritional and endocrine modulation of intracellular calcium: implications in obesity, insulin resistance and hypertension.

Authors:  M B Zemel
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

Review 9.  Targeting hypertension in patients with cardiorenal metabolic syndrome.

Authors:  Edward Rojas; Manuel Velasco; Valmore Bermúdez; Zafar Israili; Peter Bolli
Journal:  Curr Hypertens Rep       Date:  2012-10       Impact factor: 5.369

Review 10.  Role of endoplasmic reticulum stress signalling in diabetic endothelial dysfunction and atherosclerosis.

Authors:  Yunzhou Dong; Conrad Fernandes; Yanjun Liu; Yong Wu; Hao Wu; Megan L Brophy; Lin Deng; Kai Song; Aiyun Wen; Scott Wong; Daoguang Yan; Rheal Towner; Hong Chen
Journal:  Diab Vasc Dis Res       Date:  2016-10-20       Impact factor: 3.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.